IDEXX Laboratories IDXX has shown strong momentum in the last 12 months, rising 39.4%. The stock has comfortably surpassed ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IDEXX Laboratories has outperformed the broader market over the past year, and analysts remain moderately bullish about the ...

Investors with an interest in Medical - Instruments stocks have likely encountered both SONOVA HOLDING (SONVY) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value ...

IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the strong momentum in its CAG (Companion Animal Group) Diagnostics business. The company is also growing its ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the ...

While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...

I reiterate a 'Sell' rating on IDEXX due to weak U.S. clinical visits and demand, with a one-year price target of $400 per share. IDEXX's Q3 results showed a 2.1% decline in same-store clinical visits ...

This was the stock's second consecutive day of losses.

IDEXX Laboratories, Inc. (IDXX) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 9:15 AM ESTCompany ParticipantsJay Mazelsky ...

IDEXX Laboratories Inc. closed 19.62% short of its 52-week high of $769.98, which the company reached on November 26th.